SARS-CoV Overview
| Cat No. | Product Name | CAS No. | Purity | Order |
|---|---|---|---|---|
| L038499 | 6-Chloro-3-hydroxypyrazine-2-carboxamide | 259793-90-3 | ≥ 95% | Inquiry |
| L038498 | 6-Bromo-3-hydroxypyrazine-2-carboxamide | 259793-88-9 | ≥ 95% | Inquiry |
| I038546 | YH-53 | 1471484-62-4 | 98.0% | Inquiry |
| I036646 | SSAA09E2 | 883944-52-3 | 98.0% | Inquiry |
| I034464 | PF00835231 | 870153-29-0 | 98.0% | Inquiry |
| I034512 | PF-07321332 | 2628280-40-8 | 98.0% | Inquiry |
| I032886 | MUN91789 | 2144491-78-9 | 98.0% | Inquiry |
| I032744 | MPro Inhibitor 11b | 2413716-71-7 | 98.0% | Inquiry |
| I032242 | MI-1851 | 2417283-44-2 | 98.0% | Inquiry |
| I031110 | Lufotrelvir | 2468015-78-1 | 98.0% | Inquiry |
| I026767 | EIDD-1931 | 3258-02-4 | 98.0% | Inquiry |
| I021738 | ALC-0315 | 2036272-55-4 | 98.0% | Inquiry |
| I008442 | Molnupiravir | 2349386-89-4 | ≥ 95% | Inquiry |
| I016218 | SARS-CoV-IN-3 | 888958-27-8 | ≥ 95% | Inquiry |
| I016219 | SARS-CoV-IN-2 | 888958-26-7 | ≥ 95% | Inquiry |
| I016220 | SARS-CoV-IN-1 | 888958-25-6 | ≥ 95% | Inquiry |
| I016221 | Molnupiravir | 2492423-29-5 | ≥ 95% | Inquiry |
| I015463 | XP-59 | 890402-73-0 | ≥ 95% | Inquiry |
| I015465 | ML188 | 1417700-13-0 | ≥ 95% | Inquiry |
| I015222 | X77 | 2455518-33-7 | ≥ 95% | Inquiry |
| I013931 | TH1217 | 1862212-48-3 | ≥ 95% | Inquiry |
| I014344 | Direct Violet 1 | 2586-60-9 | ≥ 95% | Inquiry |
| I012192 | Symplostatin 4 | 1208232-55-6 | ≥ 95% | Inquiry |
| I012202 | SSAA09E3 | 52869-18-8 | ≥ 95% | Inquiry |
| I003308 | Aviptadil Acetate | 40077-57-4 (free base) | ≥ 95% | Inquiry |